Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study to Evaluate the Efficacy and Safety of CD07223 1.5% Gel and 0.5% Gel in Subjects With Acne

NCT01106807 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT01106807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01106807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study to Evaluate the Efficacy and Safety of CD07223 1.5% Gel and 0.5% Gel in Subjects With Acne
Lead sponsor
Galderma R&D
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2010
Completion date
September 30, 2010
Enrollment
73 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acne